- Home
- RGNX vs UROY Comparison
RGNX vs UROY Comparison
Compare RGNX & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- UROY
- Stock Information
- Founded
- RGNX 2008
- UROY 2017
- Country
- RGNX United States
- UROY Canada
- Employees
- RGNX N/A
- UROY N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- UROY
- Sector
- RGNX Health Care
- UROY
- Exchange
- RGNX Nasdaq
- UROY Nasdaq
- Market Cap
- RGNX 356.7M
- UROY 318.6M
- IPO Year
- RGNX 2015
- UROY N/A
- Fundamental
- Price
- RGNX $7.27
- UROY $2.12
- Analyst Decision
- RGNX Buy
- UROY Strong Buy
- Analyst Count
- RGNX 12
- UROY 2
- Target Price
- RGNX $33.36
- UROY $5.60
- AVG Volume (30 Days)
- RGNX 698.7K
- UROY 2.1M
- Earning Date
- RGNX 02-28-2025
- UROY 03-14-2025
- Dividend Yield
- RGNX N/A
- UROY N/A
- EPS Growth
- RGNX N/A
- UROY 256.61
- EPS
- RGNX N/A
- UROY 0.03
- Revenue
- RGNX $84,327,000.00
- UROY $27,478,292.00
- Revenue This Year
- RGNX $2.23
- UROY N/A
- Revenue Next Year
- RGNX $250.77
- UROY $6.55
- P/E Ratio
- RGNX N/A
- UROY $83.39
- Revenue Growth
- RGNX N/A
- UROY 31.26
- 52 Week Low
- RGNX $6.56
- UROY $1.86
- 52 Week High
- RGNX $28.80
- UROY $3.12
- Technical
- Relative Strength Index (RSI)
- RGNX 41.90
- UROY 37.15
- Support Level
- RGNX $6.92
- UROY $2.18
- Resistance Level
- RGNX $7.79
- UROY $2.30
- Average True Range (ATR)
- RGNX 0.44
- UROY 0.12
- MACD
- RGNX -0.04
- UROY -0.03
- Stochastic Oscillator
- RGNX 19.40
- UROY 4.17
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.